1. Home
  2. SRG vs SMTI Comparison

SRG vs SMTI Comparison

Compare SRG & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRG
  • SMTI
  • Stock Information
  • Founded
  • SRG 2014
  • SMTI 1982
  • Country
  • SRG United States
  • SMTI United States
  • Employees
  • SRG N/A
  • SMTI N/A
  • Industry
  • SRG Real Estate Investment Trusts
  • SMTI Medical/Dental Instruments
  • Sector
  • SRG Real Estate
  • SMTI Health Care
  • Exchange
  • SRG Nasdaq
  • SMTI Nasdaq
  • Market Cap
  • SRG 254.9M
  • SMTI 239.7M
  • IPO Year
  • SRG 2015
  • SMTI N/A
  • Fundamental
  • Price
  • SRG $4.57
  • SMTI $29.80
  • Analyst Decision
  • SRG
  • SMTI Buy
  • Analyst Count
  • SRG 0
  • SMTI 1
  • Target Price
  • SRG N/A
  • SMTI $44.00
  • AVG Volume (30 Days)
  • SRG 260.0K
  • SMTI 26.8K
  • Earning Date
  • SRG 11-06-2024
  • SMTI 11-11-2024
  • Dividend Yield
  • SRG N/A
  • SMTI N/A
  • EPS Growth
  • SRG N/A
  • SMTI N/A
  • EPS
  • SRG N/A
  • SMTI N/A
  • Revenue
  • SRG $59,030,000.00
  • SMTI $72,410,222.00
  • Revenue This Year
  • SRG N/A
  • SMTI $26.97
  • Revenue Next Year
  • SRG N/A
  • SMTI $18.91
  • P/E Ratio
  • SRG N/A
  • SMTI N/A
  • Revenue Growth
  • SRG 274.65
  • SMTI 21.42
  • 52 Week Low
  • SRG $3.63
  • SMTI $26.00
  • 52 Week High
  • SRG $9.87
  • SMTI $43.25
  • Technical
  • Relative Strength Index (RSI)
  • SRG 50.67
  • SMTI 43.04
  • Support Level
  • SRG $4.34
  • SMTI $28.36
  • Resistance Level
  • SRG $4.76
  • SMTI $30.97
  • Average True Range (ATR)
  • SRG 0.13
  • SMTI 1.91
  • MACD
  • SRG 0.01
  • SMTI -0.30
  • Stochastic Oscillator
  • SRG 53.49
  • SMTI 25.09

About SRG Seritage Growth Properties

Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management and leasing of diversified and mixed-use properties throughout the United States.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: